A Phase I Study Of STI 571 (Gleevec) In Combination With Cisplatin/Irinotecan In Patients With Extensive Stage Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 29 Jul 2015
At a glance
- Drugs Imatinib (Primary) ; Cisplatin; Irinotecan
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2005 New trial record.